Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000909012-99-000400
Filing Date
1999-07-15
Accepted
1999-07-15 00:00:00
Documents
4
Group Members
FLEMING ROBERT INC / DAFLEMING US DISCOVERY FUND III, L.P.FLEMING US DISCOVERY LLCFLEMING US DISCOVERY OFFSHORE FUND III, L.P.FLEMING US DISCOVERY PARTNERS, L.P.ROBERT FLEMING HOLDINGS, LTD.ROBERT FLEMING, INC.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13 SC 13D/A 43990
2 JOINT FILING AGREEMENT EX-1 10449
3 AMENDMENT TO STOCK & WARRANT PUR. AGREE. EX-5 8580
4 AMEND. 1 TO THE STOCK & WAR. PUR. AGREE. EX-7 8486
  Complete submission text file 0000909012-99-000400.txt   74243
Mailing Address 320 PARK AVE 11TH AND 12TH FL NEW YORK NY 10022
Business Address 320 PARK AVENUE 11TH & 12TH FL NEW YORK NY 10022 2125083600
FLEMING ROBERT INC / DA (Filed by) CIK: 0000902812 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0331
SIC: 0000

Mailing Address CASTOR & KENSINGTON AVENUES PHILADELPHIA PA 19124-5694
Business Address CASTOR & KENSINGTON AVES PHILADELPHIA PA 19124-5694 2152892220
GLOBAL PHARMACEUTICAL CORP \DE\ (Subject) CIK: 0001003642 (see all company filings)

EIN.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48867 | Film No.: 99664968
SIC: 2834 Pharmaceutical Preparations